The mission of Prostate Cancer Research Centre is to increase survival rates, reduce morbidity, and improve quality of life for men with prostate cancer. Our vision is a cure for the disease. We focus on developing new and improved treatments for advanced prostate cancer.
Prostate cancer becomes advanced when cancerous cells spread outside the prostate. Nearly all of the men who die of prostate cancer have advanced disease. Advanced Prostate Cancer is treated by hormone therapy, developed in the 1940s. Because hormone therapy is still the primary and most effective treatment for the disease, there has been relatively little improvement in survival for over 75 years. That is why PCRC is focused on developing new and more effective treatments for advanced prostate cancer.
We will only achieve our mission through research. We support world-class scientists to aim to develop new treatments.
Three of our research programmes - Spread of Prostate Cancer, Prostate Cancer Stem Cells & Immunotherapy - developing new treatments for prostate cancer. We have a fourth project which is developing new pre-clinical models of advanced prostate cancer.
Meet the men and women whose research is supported by PCRCRead more
Our immunotherapy group is developing therapy to help the immune cells expose the enemies and kill the cancer cellsRead more
This research is identifying the prostate cancer stem cells so that we can target and kill them.Read more
This research is identifying the genetic changes that allow prostate cancer to spread so that therapy can be developed to prevent and kill the cancer cells that have spread.Read more